Colonic diverticulosis is a common condition and although the majority of patients are asymptomatic up to 20% experience altered bowel habit and abdominal pain. The mechanisms underlying these symptoms are unclear but several theories now exist. This article briefly outlines a model of GI perception and then highlights past and current theories that may explain the development of symptoms in patients with diverticulosis.

1.
Parks TG: Natural history of diverticular disease of the colon. Clin Gastroenterol 1975;4:53–69.
2.
Simpson J, Neal KR, Scholefield JH, Spiller RC: Patterns of pain in diverticular disease and the influence of acute diverticulitis. Eur J Gastroenterol Hepatol 2003;15:1005–1010.
3.
Meissner G: Über die Nerven der Darmwand. Henle und Pfenfer A Ration Med 1857;8:364–366.
4.
Auerbach L: Fernere vorläufige Mitteilung über den Nervenapparat des Darmes. Arch Pathol Anat Physiol 1864;30:457–460.
5.
Furness JB, Costa M: The Enteric Nervous System. New York, Churchill Livingstone, 1987.
6.
Scheuermann DW, Stach W, Timmermans JP, Adriaensen D, De Groodt-Lasseel MH: Neuron-specific enolase and S-100 protein immunohistochemistry for defining the structure and topographical relationship of the different enteric nerve plexuses in the small intestine of the pig. Cell Tissue Res 1989;256:65–75.
7.
Wilson AJ, Furness JB, Costa M: The fine structure of the submucous plexus of the guinea-pig ileum. I. The ganglia, neurons, Schwann cells and neuropil. J Neurocytol 1981;10:759–784.
8.
Stohr P: Mikroskopische Studien zur Innervation des Magen-Darmkanales III. Z Zellforsch Mikrosk Anat 1934;21:243–278.
9.
Arfwidsson S: Pathogenesis of multiple diverticula of the sigmoid colon in diverticular disease. Acta Chir Scand 1964:suppl 342.
10.
Cortesini C, Pantalone D: Usefulness of colonic motility study in identifying patients at risk for complicated diverticular disease. Dis Colon Rectum 1991;34:339–342.
11.
Eastwood MA, Smith AN, Brydon WG, Pritchard J: Colonic function in patients with diverticular disease. Lancet 1978;i:1181–1182.
12.
Eastwood MA, Watters DA, Smith AN: Diverticular disease – is it a motility disorder? Clin Gastroenterol 1982;11:545–561.
13.
Weinreich J, Andersen D: Intraluminal pressure in the sigmoid colon. II. Patients with sigmoid diverticula and related conditions. Scand J Gastroenterol 1976;11:581–586.
14.
Morson BC: Pathology of diverticular disease of the colon. Clin Gastroenterol 1975;4:37–52.
15.
Connell AM: Applied physiology of the colon: factors relevant to diverticular disease. Clin Gastroenterol 1975;4:23–36.
16.
Clemens CH, Samsom M, Roelofs J, van Berge Henegouwen GP, Smout AJ: Colorectal visceral perception in diverticular disease. Gut 2004;53:717–722.
17.
Diop L, Raymond F, Fargeau H, Petoux F, Chovet M, Doherty AM: Pregabalin (CI-1008) inhibits the trinitrobenzene sulfonic acid-induced chronic colonic allodynia in the rat. J Pharmacol Exp Ther 2002;302:1013–1022.
18.
Huizinga JD, Waterfall WE, Stern HS: Abnormal myogenic control activity in colonic smooth muscle from diverticular disease patients. Proc Smooth Muscle Function Symp, 1986, Banff.
19.
Huizinga JD, Waterfall WE, Stern HS: Abnormal response to cholinergic stimulation in the circular muscle layer of the human colon in diverticular disease. Scand J Gastroenterol 1999;34:683–688.
20.
Hyland JM, Darby CF, Hammond P, Taylor I: Myoelectrical activity of the sigmoid colon in patients with diverticular disease and the irritable colon syndrome suffering from diarrhoea. Digestion 1980;20:293–299.
21.
Bassotti G, Battaglia E, De Roberto G, Morelli A, Tonini M, Villanacci V: Alterations in colonic motility and relationship to pain in colonic diverticulosis. Clin Gastroenterol Hepatol 2005;3:248–253.
22.
Reilly M: Sigmoid myotomy. Br J Surg 1966;53:859–863.
23.
Eastwood MA, Smith AN, Brydon WG, Pritchard J: Comparison of bran, ispaghula, and lactulose on colon function in diverticular disease. Gut 1978;19:1144–1147.
24.
Findlay JM, Smith AN, Mitchell WD, Anderson AJ, Eastwood MA: Effects of unprocessed bran on colon function in normal subjects and in diverticular disease. Lancet 1974;i:146–149.
25.
Horgan AF, McConnell EJ, Wolff BG, The S, Paterson C: Atypical diverticular disease: surgical results. Dis Colon Rectum 2001;44:1315–1318.
26.
Tursi A, Papagrigoriadis S: Review article: the current and evolving treatment of colonic diverticular disease. Aliment Pharmacol Ther 2009;30:532–546.
27.
Colecchia A, Sandri L, Capodicasa S, et al: Diverticular disease of the colon: new perspectives in symptom development and treatment. World J Gastroenterol 2003;9:1385–1389.
28.
Simpson J, Sundler F, Humes DJ, Jenkins D, Scholefield JH, Spiller RC: Post inflammatory damage to the enteric nervous system in diverticular disease and its relationship to symptoms. Neurogastroenterol Motil 2009;21:847–e858.
29.
Simpson J, Sundler F, Humes DJ, et al: Prolonged elevation of galanin and tachykinin expression in mucosal and myenteric enteric nerves in trinitrobenzene sulphonic acid colitis. Neurogastroenterol Motil 2008;20:392–406.
30.
Humes DJ, Simpson J, Smith J, et al: Visceral hypersensitivity in diverticular disease and the role of low grade inflammation and NK1 and GALR1 receptors. Neurogastroenterol Motil 2008;20(suppl 1):3.
31.
Jeyarajah S, Papagrigoriadis S: Review article: the pathogenesis of diverticular disease – current perspectives on motility and neurotransmitters. Aliment Pharmacol Ther 2011;33:789–800.
32.
Spiller RC, Humes DJ, Campbell E, et al: The Patient Health Questionnaire 12 Somatic Symptom scale as a predictor of symptom severity and consulting behaviour in patients with irritable bowel syndrome and symptomatic diverticular disease. Aliment Pharmacol Ther 2010;32:811–820.
33.
Humes DJ, Simpson J, Neal KR, Scholefield JH, Spiller RC: Psychological and colonic factors in painful diverticulosis. Br J Surg 2008;95:195–198.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.